2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Differential Retinoic Acid Signaling in the Hippocampus of Aged Rats with and without Memory Impairment

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Retinoic acid (RA), a metabolite of vitamin A, has many physiological functions, and mounting evidence points to important roles in cognition. In vitro experiments indicate that RA is involved in homeostatic synaptic scaling in the hippocampus, which supports overall network stability during learning. It has been previously determined that disrupted RA signaling in the hippocampus causes deterioration of memory, that RA signaling declines with age in brain, and that application of RA reverses this decline. Here, we explore whether RA signaling is altered in an animal model of neurocognitive aging. We used a Morris water maze protocol to study cognitive decline in aged rats, which assesses hippocampus-dependent spatial memory and reveals substantial interindividual differences in aged animals. Aged unimpaired (AU) rats perform on par with young (Y), while aged impaired (AI) animals exhibit spatial memory deficits. We show that the major substrate for RA, retinol binding protein 4 (RBP4), is decreased in AU rats, and retinol cell surface receptor declines with chronological age. Other affected components of RA signaling include selective increases in AI animals in hippocampal synthesis (RALDH1) and catabolism of RA (CYP26B1), RA receptor α, the RA regulated ionotropic glutamate receptor (GluR1), as well as fragile X mental retardation protein (FMRP). The results support the conclusion that, surprisingly, increased RA signaling in the aged hippocampus is associated with poor cognitive outcome.

          Related collections

          Most cited references77

          • Record: found
          • Abstract: found
          • Article: not found

          Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.

          In obesity and type 2 diabetes, expression of the GLUT4 glucose transporter is decreased selectively in adipocytes. Adipose-specific Glut4 (also known as Slc2a4) knockout (adipose-Glut4(-/-)) mice show insulin resistance secondarily in muscle and liver. Here we show, using DNA arrays, that expression of retinol binding protein-4 (RBP4) is elevated in adipose tissue of adipose-Glut4(-/-) mice. We show that serum RBP4 levels are elevated in insulin-resistant mice and humans with obesity and type 2 diabetes. RBP4 levels are normalized by rosiglitazone, an insulin-sensitizing drug. Transgenic overexpression of human RBP4 or injection of recombinant RBP4 in normal mice causes insulin resistance. Conversely, genetic deletion of Rbp4 enhances insulin sensitivity. Fenretinide, a synthetic retinoid that increases urinary excretion of RBP4, normalizes serum RBP4 levels and improves insulin resistance and glucose intolerance in mice with obesity induced by a high-fat diet. Increasing serum RBP4 induces hepatic expression of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) and impairs insulin signalling in muscle. Thus, RBP4 is an adipocyte-derived 'signal' that may contribute to the pathogenesis of type 2 diabetes. Lowering RBP4 could be a new strategy for treating type 2 diabetes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.

            Elevated hippocampal activation is observed in conditions that confer risk for Alzheimer's disease, including amnestic mild cognitive impairment (aMCI). Studies in relevant animal models have indicated that overactivity in selective hippocampal circuits contributes to cognitive impairment. Here, we tested the effect of reducing hippocampal activation in aMCI. Under placebo treatment, hippocampal activation in the dentate gyrus/CA3 was elevated in aMCI patients compared to a healthy control group. By using a low dose of the antiepileptic levetiracetam hippocampal activation in aMCI was reduced to a level that did not differ from the control group. Compared to aMCI memory performance under placebo, performance in the scanning task was significantly improved under drug treatment. Contrary to the view that greater hippocampal activation might serve a beneficial function, these results support the view that increased hippocampal activation in aMCI is a dysfunctional condition and that targeting excess hippocampal activity has therapeutic potential. Copyright © 2012 Elsevier Inc. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Synaptic signaling by all-trans retinoic acid in homeostatic synaptic plasticity.

              Normal brain function requires that the overall synaptic activity in neural circuits be kept constant. Long-term alterations of neural activity lead to homeostatic regulation of synaptic strength by a process known as synaptic scaling. The molecular mechanisms underlying synaptic scaling are largely unknown. Here, we report that all-trans retinoic acid (RA), a well-known developmental morphogen, unexpectedly mediates synaptic scaling in response to activity blockade. We show that activity blockade increases RA synthesis in neurons and that acute RA treatment enhances synaptic transmission. The RA-induced increase in synaptic strength is occluded by activity blockade-induced synaptic scaling. Suppression of RA synthesis prevents synaptic scaling. This form of RA signaling operates via a translation-dependent but transcription-independent mechanism, causes an upregulation of postsynaptic glutamate receptor levels, and requires RARalpha receptors. Together, our data suggest that RA functions in homeostatic plasticity as a signaling molecule that increases synaptic strength by a protein synthesis-dependent mechanism.
                Bookmark

                Author and article information

                Journal
                eNeuro
                eNeuro
                eneuro
                eneuro
                eNeuro
                eNeuro
                Society for Neuroscience
                2373-2822
                20 August 2021
                14 September 2021
                Sep-Oct 2021
                : 8
                : 5
                : ENEURO.0120-21.2021
                Affiliations
                [1 ]Laboratory of Behavioral Neuroscience, Neurocognitive Aging Section, National Institute on Aging , Baltimore, MD 21224
                [2 ]Institute of Medical Science, School of Medical Sciences, University of Aberdeen, Foresterhill , Aberdeen AB25 2ZD, Scotland, United Kingdom
                Author notes

                P.J.M is non-executive director of Nevrargenics Ltd, a company developing synthetic retinoids for use in neurodegenerative disease. All other authors declare no competing financial interests.

                Author contributions: M.U.W.-F., P.J.M., and P.R.R. designed research; M.U.W.-F., S.L.R., and J.M.L. performed research; M.U.W.-F. and J.M.L. analyzed data; M.U.W.-F., S.L.R., J.M.L., P.J.M., and P.R.R. wrote the paper.

                This work was entirely supported by the Intramural Research Program of the National Institutes of Health, National institute on Aging.

                M. U. Wołoszynowska-Fraser’s present address: School of Life Sciences, Keele University, Keele Staffordshire, ST5 5BG, United Kingdom.

                Correspondence should be addressed to Peter R. Rapp at rappp@ 123456mail.nih.gov .
                Author information
                https://orcid.org/0000-0002-0983-3944
                Article
                eN-NWR-0120-21
                10.1523/ENEURO.0120-21.2021
                8442538
                34417282
                da421d0b-85f0-454d-9103-8833b351d9e2
                Copyright © 2021 Wołoszynowska-Fraser et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

                History
                : 22 March 2021
                : 9 August 2021
                : 17 August 2021
                Page count
                Figures: 6, Tables: 1, Equations: 0, References: 77, Pages: 14, Words: 00
                Funding
                Funded by: http://doi.org/10.13039/501100000268Biotechnology and Biological Sciences Research Council (BBSRC)
                Award ID: BB/P004806/1
                Funded by: National Health Service (NHS) Grampian Endowments
                Award ID: 16/11/55
                Funded by: http://doi.org/10.13039/100000049HHS | NIH | National Institute on Aging (NIA)
                Award ID: ZIA AG000350
                Categories
                1
                Research Article: New Research
                Cognition and Behavior
                Custom metadata
                September/October 2021

                aging,hippocampus,memory,retinoic acid,spatial,vitamin a
                aging, hippocampus, memory, retinoic acid, spatial, vitamin a

                Comments

                Comment on this article